Fifth Third Bancorp
CGON icon

Fifth Third Bancorp’s CG Oncology CGON Stock Holding History

Fifth Third Bancorp’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.2K Sell
959
-131
-12% -$8.56K ﹤0.01% 3112
2026
Q1 		$73.8K Buy
+1,090
New +$61.8K ﹤0.01% 3036

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fifth Third Bancorp's CGON Position: Q2 2026 in Review

Fifth Third Bancorp reduced its CG Oncology (CGON) stake by 12% in Q2 2026, selling an estimated $8.56K and leaving 959 shares worth $68.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3112.

Fifth Third Bancorp first reported a position in CGON in Q1 2026 and has held it in 2 quarters since. The position peaked at $73.8K in Q1 2026. 228 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Fifth Third Bancorp held 959 shares of CG Oncology worth $68.2K as of Q2 2026.
  • Fifth Third Bancorp sold 131 CG Oncology shares in Q2 2026, an estimated $8.56K.
  • CG Oncology made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3112 holding.
  • Fifth Third Bancorp first reported a position in CG Oncology in Q1 2026 and has held it in 2 quarters since.
  • Fifth Third Bancorp's CG Oncology position peaked at $73.8K in Q1 2026.
  • 228 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.